KBU2046, CAS [[1143863-69-7]]

Produktübersicht

• Artikelname: KBU2046, CAS [[1143863-69-7]]
• Artikelnummer: MCE-HY-120548
• Hersteller Artikelnummer: HY-120548
• Alternativnummer: MCE-HY-120548-25MG,MCE-HY-120548-50MG,MCE-HY-120548-10MMX1ML,MCE-HY-120548-100MG,MCE-HY-120548-5MG,MCE-HY-120548-10MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien

Produktbeschreibung

KBU2046 is an orally active transforming growth factor-beta (TGF-beta1) inhibitor. KBU2046 reduces integrin family protein expression, decreases Raf, RIPK1 and ERK phosphorylation to deactivate the ERK signaling pathway, and down-regulates genes linked to TGF-beta1 maturation. KBU2046 suppresses tumor cell motility, impedes cancer invasion and metastasis, and inhibits human ESCC growth and metastasis in a murine model. KBU2046 can be used for the researches of triple-negative breast cancer and esophageal squamous cell carcinoma[1][2].

Produkteigenschaften

• Molekulargewicht: 242.25
• Reinheit: 99.52
• CAS Nummer: [1143863-69-7]
• Formel: C15H11FO2
• Target-Kategorie: ERK,Integrin,Raf,RIP kinase,TGF-beta Receptor

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound